Apixaban for the Secondary Prevention of Thromboembolism: A Prospective Randomized Outcome Pilot Study Among Patients With the AntiphosPholipid Syndrome
Phase of Trial: Phase IV
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Apixaban (Primary) ; Warfarin
- Indications Thromboembolism
- Focus Adverse reactions; Therapeutic Use
- Acronyms ASTRO-APS
- 29 Dec 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2019.
- 29 Dec 2016 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2019.
- 05 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.